News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

MicroTest Laboratories Release: The Impact Of The Drug Quality And Security Act On Compounding Pharmacies Is The Subject Of May 13th Seminar In Boston


4/29/2014 9:12:11 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

AGAWAM, Mass., April 29, 2014 (GLOBE NEWSWIRE) -- A seminar focusing on the impact of HR3204 — the Drug Quality and Security Act — on compound pharmacies and manufacturers is the subject of a seminar set for May 13, 2014 in Dedham, Mass., near Boston.

Help employers find you! Check out all the jobs and post your resume.

Read at GlobeNewswire

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES